Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.3394 USD | +0.80% | -4.15% | +102.02% |
Financials (USD)
Sales 2023 * | 11.71M | Sales 2024 * | 18.52M | Capitalization | 99.49M |
---|---|---|---|---|---|
Net income 2023 * | -4M | Net income 2024 * | -1M | EV / Sales 2023 * | 8.5 x |
Net cash position 2023 * | - | Net cash position 2024 * | - | EV / Sales 2024 * | 5.37 x |
P/E ratio 2023 * |
-17
x | P/E ratio 2024 * |
-
| Employees | 33 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 85.64% |
Latest transcript on BioLargo, Inc.
1 day | +0.80% | ||
1 week | -4.15% | ||
Current month | -13.31% | ||
1 month | -6.09% | ||
3 months | +98.71% | ||
6 months | +99.65% | ||
Current year | +102.02% |
Managers | Title | Age | Since |
---|---|---|---|
Dennis Calvert
CEO | Chief Executive Officer | 61 | 02-05-31 |
Director of Finance/CFO | 68 | 08-01-31 | |
Chief Operating Officer | 55 | 02-05-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Dennis Marshall
BRD | Director/Board Member | 81 | 06-04-27 |
Kenneth Code
CTO | Chief Tech/Sci/R&D Officer | 77 | 07-03-31 |
Dennis Calvert
CEO | Chief Executive Officer | 61 | 02-05-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-27 | 0.3394 | +0.80% | 328,005 |
24-03-26 | 0.3367 | -2.25% | 257,744 |
24-03-25 | 0.3445 | +1.34% | 781,787 |
24-03-22 | 0.34 | -5.58% | 446,249 |
24-03-21 | 0.36 | +1.67% | 352,299 |
Delayed Quote OTC Markets, March 27, 2024 at 03:51 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+102.02% | 99.49M | |
+9.90% | 109B | |
-7.78% | 61.6B | |
+3.80% | 34.64B | |
+9.05% | 31.17B | |
+8.28% | 33.41B | |
+8.85% | 19.53B | |
+9.18% | 18.93B | |
+5.01% | 15.7B | |
+3.86% | 14.64B |